Chen Schor
2022
In 2022, Chen Schor earned a total compensation of $4M as President and Chief Executive Officer at Adicet Bio, a 59% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $309,540 |
|---|---|
| Option Awards | $3,088,443 |
| Salary | $562,285 |
| Other | $27,751 |
| Total | $3,988,018 |
Schor received $3.1M in option awards, accounting for 77% of the total pay in 2022.
Schor also received $309.5K in non-equity incentive plan, $562.3K in salary and $27.8K in other compensation.
Rankings
In 2022, Chen Schor's compensation ranked 857th out of 5,625 executives tracked by ExecPay. In other words, Schor earned more than 84.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 857 out of 5,625 | 85th |
Division Manufacturing | 389 out of 3,053 | 87th |
Major group Chemicals And Allied Products | 133 out of 1,380 | 90th |
Industry group Drugs | 120 out of 1,281 | 91st |
Industry Pharmaceutical Preparations | 92 out of 927 | 90th |
Source: SEC filing on April 18, 2023.
Schor's colleagues
We found two more compensation records of executives who worked with Chen Schor at Adicet Bio in 2022.
News
Adicet Bio CEO Chen Schor's 2022 pay falls 59% to $4M
April 18, 2023
Adicet Bio CEO Chen Schor's 2021 pay slips 13% to $9.8M
April 21, 2022
Adicet Bio CEO Chen Schor's 2020 pay jumps 306% to $11M
March 18, 2021
Adicet Bio CEO Chen Schor's 2019 pay slips 10% to $2.8M
March 27, 2020
Adicet Bio CEO Chen Schor's 2018 pay jumps 537% to $3.1M
March 27, 2019